Oscar Health, Inc. (OSCR): BCG Matrix [Apr-2026 Updated]

You're looking at Oscar Health's current capital allocation puzzle, and mapping their business units onto the BCG Matrix gives us the clearest picture of where the money is flowing right now. The engine is clearly the Individual & Small Group ACA Marketplace, a Star segment driving nearly $12.1 billion in projected 2025 revenue with membership up 28%, but it's burning cash, projecting a loss between $200 million and $300 million. On the other hand, operational leverage is finally showing in the core business, with SG&A dropping to 17.5%, suggesting some units are maturing into Cash Cows, while the Cigna+Oscar Partnership has defintely shrunk into a Dog, down to just over 10,000 members. We need to see if the high-potential Question Marks-like the +Oscar platform and new state rollouts-can transition into future Stars, so let's break down this portfolio now.

Background of Oscar Health, Inc. (OSCR)

You're looking at Oscar Health, Inc. (OSCR), which is definitely a different kind of player in the U.S. health insurance game. Founded back in 2012 in New York City by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, the whole idea was to fix a system they found frustratingly complex. Their vision, which still drives the company under CEO Mark Bertolini, centers on making healthcare simple, transparent, and human-centered by leaning heavily on technology. That tech focus is key; it's what separates Oscar Health from a lot of the legacy carriers you might be used to analyzing.

Oscar Health operates primarily by offering Individual & Family plans, which you know are the plans people buy on the Affordable Care Act (ACA) marketplaces. But they also sell their full-stack technology platform, called +Oscar, to power other healthcare entities. As of September 30, 2025, the company had grown its membership base to approximately 2.1 million members. That's a significant footprint for a company that started only a little over a decade ago.

Let's look at the numbers as of the third quarter of 2025, which gives us a solid late-2025 snapshot. For the three months ended September 30, 2025, Oscar Health posted total revenue of approximately $2,985,984 thousand. However, this growth came with pressure on profitability; the loss from operations for that quarter was $(129,250) thousand, leading to a net loss attributable of $(137,450) thousand. The Medical Loss Ratio (MLR)-that's the percentage of premiums paid out in claims-was running high at 88.5% for the quarter, reflecting increased member utilization across the market.

Looking at the bigger picture for the full year 2025, management reaffirmed its guidance, projecting total revenues to land between $12.0 billion and $12.2 billion. Still, they are bracing for an operating loss for the year, guided to be between $200 million and $300 million. This financial picture shows a company rapidly scaling its top line but navigating near-term headwinds from higher-than-expected medical costs, which is why you see those losses in the recent quarters. Anyway, they are banking on disciplined pricing actions for 2026 to get them back to profitability next year.

Oscar Health, Inc. (OSCR) - BCG Matrix: Stars

You're analyzing the core growth engine of Oscar Health, Inc. (OSCR), which firmly sits in the Star quadrant-high market share growth in a market that is still expanding, but demanding heavy reinvestment to maintain that leadership position.

Individual & Small Group ACA Marketplace: Membership surged 28% to 2.1 million members by Q3 2025, showing high market share growth.

The membership base shows the high-growth market penetration. By the end of the third quarter of 2025, total membership reached 2.12 million members, marking a 28% year-over-year increase. This growth in the Individual and Small Group Affordable Care Act (ACA) Marketplace is the primary indicator of high relative market share in a growing segment.

Core Revenue Engine: Full-year 2025 revenue is projected at the midpoint of $12.1 billion, a high-growth top-line figure.

The top-line performance reflects this market capture. Full-year 2025 total revenue is projected to be between $12.0 billion and $12.2 billion. For context on the growth rate, third quarter 2025 revenue was approximately $2.99 billion, which is a 23.2% increase compared to the third quarter of 2024 revenue of $2.4 billion.

Technology-Driven Scale: The proprietary tech platform drives rapid expansion and member engagement in a high-growth market.

This segment's leadership is underpinned by operational efficiency gains, even while investing heavily. The Selling, General, and Administrative (SG&A) expense ratio improved to 17.5% in the third quarter of 2025, down from 19.0% in the third quarter of 2024. This leverage is key to scaling the technology platform.

High Investment Requirement: This segment still requires significant cash to fund operations, as the company projects a $200 million to $300 million Loss from Operations for 2025.

The high growth demands high cash consumption. For the full year 2025, Oscar Health, Inc. projects a Loss from Operations in the range of $200 million to $300 million. The third quarter 2025 Loss from Operations was $129.3 million, compared to a loss of $48.4 million in the third quarter of 2024. The projected full-year Medical Loss Ratio (MLR) is set between 86.0% and 87.0%.

Here's a quick look at the key financial and operational metrics supporting this Star positioning:

The investment focus remains on sustaining this growth trajectory, which is necessary to convert these market leaders into future Cash Cows when market growth inevitably slows. The company is actively managing the cost side, as evidenced by the improved SG&A ratio, but the underlying medical costs, reflected in the MLR, still require significant funding.

• Membership surged 28% year-over-year by Q3 2025.
• Full-year revenue guidance midpoint is $12.1 billion.
• Projected full-year operating loss is between $200 million and $300 million.
• Q3 2025 Adjusted EBITDA loss was $101.5 million.
• The company plans to resubmit 2026 rate filings covering approximately 98% of current membership.

Oscar Health, Inc. (OSCR) - BCG Matrix: Cash Cows

You're looking at the established, high-market-share business units of Oscar Health, Inc. that are now generating the necessary cash to fund the rest of the portfolio. These are the mature segments, primarily the core Individual market, where the heavy lifting for market penetration is done, and now you focus on efficiency.

Operational Leverage (SG&A)

The cost discipline really shows up here. The Selling, General, and Administrative (SG&A) expense ratio improved to 17.5% in the third quarter of 2025. That's a meaningful improvement of approximately 150 basis points year-over-year, which demonstrates fixed cost leverage from the scale achieved. Honestly, this efficiency is what turns a mature business into a true cash generator.

Here's a quick look at how that administrative efficiency stacks up against the prior year:

Established Market Footprint

The Individual market remains the stabilizing base, providing premium revenue from a large, established pool of members. Oscar Health ended the third quarter of 2025 with 2.1 million members, representing a 28% increase year-over-year. The CEO noted that the Individual market serves 22 million people who power the economy, showing the sheer size of the mature space Oscar Health is leading in. You want to maintain this base, not spend heavily to grow it further, but to keep it efficient.

Key membership and scale figures as of the latest reporting:

• Members as of September 30, 2025: 2.1 million
• Year-over-year membership increase (Q3 2025): 28%
• Total Revenue in Q3 2025: approximately $3.0 billion
• Total Revenue for the nine months ended September 30, 2025: approximately $8.9 billion

Improving Gross Margin

While medical costs, reflected in the Medical Loss Ratio (MLR), were up in the quarter due to higher market morbidity, the underlying structure is being managed for margin expansion. The Q3 2025 MLR was 88.5%, compared to 84.6% in Q3 2024. Still, the nine-month MLR through September 30, 2025, stood at 84.8%. The focus here is using the scale to drive down the SG&A component of the cost structure, which is showing success, to offset medical volatility.

Capital Structure Management

Oscar Health, Inc. took proactive steps to manage its debt load, which directly frees up cash flow that would otherwise go to interest payments. On November 5, 2025, the company executed a partial exchange of its 7.25% Convertible Senior Notes due 2031. Specifically, approximately $187.5 million aggregate principal amount of Notes were exchanged for approximately 23.3 million shares of Class A common stock. This move is defintely about optimizing the balance sheet. The company ended the third quarter with approximately $4.8 billion of cash and investments overall, and its insurance subsidiaries maintained approximately $1.2 billion of capital and surplus.

Finance: draft 13-week cash view by Friday.

Oscar Health, Inc. (OSCR) - BCG Matrix: Dogs

Dogs are business units or products with a low market share in low growth markets. These units frequently break even or consume cash without significant return, making them candidates for divestiture. For Oscar Health, Inc., this quadrant is populated by products and partnerships that have been strategically wound down or exited due to poor performance metrics like Medical Loss Ratio (MLR) or failure to achieve necessary scale.

The Cigna+Oscar Partnership serves as a clear example of a unit that contracted rapidly, indicating low market share capture in its segment or an unsustainable cost structure. Membership in this co-branded channel fell sharply, declining from 58,293 members as of June 30, 2024, to just 10,090 as of June 30, 2025. Oscar Health, Inc. made the decision not to renew this small group offering for 2025, focusing instead on the ICHRA (individual coverage health reimbursement arrangements) market. This exit was part of a strategic pivot away from products that could not reach a profitable place. The overall company MLR in Q2 2025 reached 91.1%, a significant increase from 79.0% in Q2 2024, highlighting the challenging cost environment that likely pressured this partnership.

Non-Core, Legacy Products represent other areas where Oscar Health, Inc. has deliberately reduced its footprint. These are products that are not material to the projected full-year 2025 Total Revenue guidance of $12.0 billion to $12.2 billion. The company has actively pruned its portfolio to concentrate resources on the core Individual market.

• Medicare Advantage market exit completed at the end of 2022.
• Cigna+Oscar small group offering discontinued in 2025.
• Any remaining small, non-ACA compliant plans being phased out.

Unprofitable Geographic Exits reflect markets where the low market share and high costs, often driven by poor risk adjustment outcomes or unsustainably high MLRs, made continued operation unviable. Expensive turn-around plans were avoided in favor of strategic withdrawal to reduce distraction and focus on markets where Oscar Health, Inc. sees a right to win. The company previously withdrew from Arkansas and Colorado in 2023.

• Exits in Arkansas and Colorado occurred in 2023.
• Reasons included never achieving scale and increased compliance work.
• The company is refiling 2026 rates covering approximately 98% of current membership to reflect higher market risk scores.

The overall financial pressure in 2025, evidenced by a Q2 2025 Loss from Operations of $230.5 million and a net loss of $228.4 million, reinforces the strategy of minimizing investment in these low-return segments to focus on scaling profitable core offerings.

Oscar Health, Inc. (OSCR) - BCG Matrix: Question Marks

You're analyzing Oscar Health, Inc. (OSCR) as a Question Mark-a business unit in a high-growth market but with a low current market share. These areas consume cash now, hoping to become Stars later. Honestly, the key here is deciding where to place your bets for the next big payoff.

New Geographic Expansions

Oscar Health is aggressively pursuing growth by entering new areas, which fits the Question Mark profile perfectly: high market growth potential but low initial penetration. For the 2025 Open Enrollment period, the Oscar experience was available in 504 counties across 18 states. The plan for 2026 involves expanding this footprint to 573 counties across 20 states. This planned expansion includes new state entries into Alabama and Mississippi. You're essentially funding a land grab here; the hope is that these new markets, currently low-share, will quickly adopt the Oscar model and grow into Stars.

Here's a snapshot of the expansion context:

• 2025 Individual Market Footprint: 504 counties in 18 states.
• Planned 2026 Footprint: 573 counties in 20 states.
• New State Entries for 2026: Alabama and Mississippi.
• The expansion represents a push into high-growth potential areas where profitability is not yet proven.

Individual Coverage Health Reimbursement Arrangements (ICHRA)

The push into ICHRA is a structural repositioning to capture a rapidly growing segment of the employer-sponsored market. ICHRA adoption grew 29% in 2024 alone. Oscar Health launched new ICHRA products in 2025, including a partnership with Hy-Vee, Inc. in the Midwest. The potential scale is massive; CEO Mark Bertolini estimated that if all employers with under 1,000 employees adopted ICHRAs, Oscar's targetable market could jump from 21 million to 96 million lives. This is a clear investment to gain share, as Oscar intends to grow its overall market share from 13% now to 18% by 2027.

The ICHRA opportunity metrics are compelling:

+Oscar Platform

The technology-as-a-service offering, branded as +Oscar, is a high-potential area that requires sustained investment to scale its value proposition beyond Oscar Health's own insurance operations. While management is currently prioritizing profitability in the insurance business, the platform's capabilities are being monetized. As of Q3 2025, Oscar Health was serving over 500k external client lives through the +Oscar platform. The technology is proving its efficiency internally; the platform automates 96% of claims under \$30K with 98.5% accuracy. This segment consumes cash for development but has the potential to become a significant, high-margin revenue stream, which is why you keep funding the R&D.

Medicare Advantage (MA) Plans

Medicare Advantage plans represent a highly competitive, capital-intensive segment. While the overall MA market is a \$600 billion market, the growth backdrop for 2025 is slowing, with market growth expected to decline to 2% between 2024 and 2025. Oscar Health is navigating this by focusing on areas where it can overlap its existing Medicaid footprint. For Oscar Health, this is a classic Question Mark: a massive, growing market where the company has a small presence, requiring significant capital and regulatory navigation to build share against established giants. Success here could definitely transition this unit into a Cash Cow.

Consider the context of Oscar Health's overall performance as of mid-2025:

• Q3 2025 Revenue: \$3.0 billion.
• Q3 2025 Membership: 2.1 million members.
• Projected 2025 Full-Year Revenue Guidance: \$12.0 billion to \$12.2 billion.
• Projected 2025 Loss from Operations: \$200 million to \$300 million.

Finance: draft 13-week cash view by Friday.